Senda Ajroud-Driss

Grants

Grants per year 1999 2020 2021 2022 2027

• 23 Active
• 56 Finished

Grants per year

Search results

• Finished

  ALS/MND Natural History Repository

  Ajroud-Driss, S. (PD/PI)

  Massachusetts General Hospital

  12/1/23 → 11/30/24

  Project: Research project

• Master Site Agreement ALL ALS West

  Ajroud-Driss, S. (PD/PI)

  St. Joseph’s Hospital and Medical Center, National Institute of Neurological Disorders and Stroke

  9/22/23 → 9/22/24

  Project: Research project

• Prot #QRL-201-01: A Multi-center, Randomized, Double-blind, Placebo-controlled Multiple-ascending Dose Study to Evaluate the Safety and Tolerability of Qrl-201 in Amyotrophic Lateral Sclerosis

  Ajroud-Driss, S. (PD/PI)

  Worldwide Clinical Trials, Inc., QurAlis Corporation

  4/6/23 → 10/6/24

  Project: Research project

• HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) G to Master Protocol DNL343

  Ajroud-Driss, S. (PD/PI)

  Massachusetts General Hospital, Denali Therapeutics Inc.

  3/23/23 → 12/4/24

  Project: Research project

• Fixed Price Reimbursement for Longitudinal Biofluids Core

  Ajroud-Driss, S. (PD/PI)

  Target ALS Foundation, Inc.

  11/1/22 → 10/31/24

  Project: Research project

• Longitudinal Biofluids Core

  Ajroud-Driss, S. (PD/PI) & Ajroud-Driss, S. (PD/PI)

  Target ALS Foundation, Inc.

  11/1/22 → 10/31/24

  Project: Research project

• Main Account

  Ajroud-Driss, S. (PD/PI) & Ajroud-Driss, S. (PD/PI)

  Columbia University, ALS Association

  8/1/22 → 7/31/24

  Project: Research project

• Cure SMA Care Center Network and Clinical Data Registry

  Ajroud-Driss, S. (PD/PI), Ajroud-Driss, S. (PD/PI) & Ajroud-Driss, S. (PD/PI)

  Families of Spinal Muscular Atrophy

  6/1/22 → 5/20/24

  Project: Research project

• HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) E to Master Protocol TREHALOSE S-005

  Ajroud-Driss, S. (PD/PI)

  Massachusetts General Hospital, NexMed, Inc.

  3/1/22 → 12/4/24

  Project: Research project

• UMMS-ASO-STMN2 Study

  Ajroud-Driss, S. (PD/PI) & Ajroud-Driss, S. (PD/PI)

  Hopewell Fund

  11/1/21 → 11/2/22

  Project: Research project

• I AM ALS: Expanded Access Protocol (EAP) Program Proposal

  Ajroud-Driss, S. (PD/PI)

  Massachusetts General Hospital, I AM ALS

  9/3/21 → 12/31/22

  Project: Research project

• Prot# VMALS-002-2: A Phase 2a, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety of Engensis in Participants with Amyotrophic Lateral Sclerosis

  Ajroud-Driss, S. (PD/PI)

  Worldwide Clinical Trials, Inc., ViroMed Co., Ltd.

  4/29/21 → 8/15/24

  Project: Research project

• Prot# MT-1186-A02: A Phase 3b, Multicenter, Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Oral Edaravone Administered for a Period of 48 Weeks in Subjects with Amyotrophic Lateral Sclerosis (ALS)

  Ajroud-Driss, S. (PD/PI)

  ICON Clinical Research, LLC, Mitsubishi Tanabe Pharma America, Inc.

  3/16/21 → 6/30/24

  Project: Research project

• HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) A to Master Protocol ZILUCOPLAN | Home Spirometry and Open-Label Extension (OLE) Period

  Ajroud-Driss, S. (PD/PI)

  Massachusetts General Hospital, Ra Pharmaceuticals, Inc.

  3/15/21 → 3/14/24

  Project: Research project

• HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) B to Master Protocol Verdiperstat | Home Spirometry and Open-Label Extension (OLE) Period

  Ajroud-Driss, S. (PD/PI)

  Massachusetts General Hospital, Biohaven Pharmaceuticals, Inc.

  3/15/21 → 3/14/24

  Project: Research project

• HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) C to Master Protocol CNM-Au8 | Home Spirometry and Open-Label Extension (OLE) Period

  Ajroud-Driss, S. (PD/PI) & Ajroud-Driss, S. (PD/PI)

  Massachusetts General Hospital, Clene Nanomedicine, Inc.

  3/15/21 → 3/14/24

  Project: Research project

• HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) D to Master Protocol Pridopidine | Double-Blind Phase

  Ajroud-Driss, S. (PD/PI) & Ajroud-Driss, S. (PD/PI)

  Massachusetts General Hospital

  11/20/20 → 12/31/23

  Project: Research project

• Prot #233AS101: A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB067 Administered to Adult Subjects with Amyotrophic Lateral Sclerosis and Confirmed Superoxide Dismutase 1 Mutation

  Ajroud-Driss, S. (PD/PI)

  Quintiles, Inc., Biogen MA Inc.

  9/9/20 → 9/9/23

  Project: Research project

• Radicava®/(Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)

  Ajroud-Driss, S. (PD/PI)

  Massachusetts General Hospital, Mitsubishi Tanabe Pharma America, Inc.

  8/3/20 → 9/30/24

  Project: Research project

• PLS Natural History Study

  Ajroud-Driss, S. (PD/PI)

  Columbia University, Spastic Paraplegia Foundation, Inc.

  7/15/20 → 7/14/22

  Project: Research project

  • Conference Calls 100%
  • Natural History Study 100%
  • Specific Task 100%

• Emerging Real-World Use of Nusinersen in Adult Patients with Spinal Muscular Atrophy (SMA) in the US: A Multi-Site Chart Review Study

  Ajroud-Driss, S. (PD/PI)

  Analytica La-Ser International, Inc., Biogen Inc.

  7/6/20 → 7/6/23

  Project: Research project

• Prot #ALN-TTR02-012: A Phase 4 Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients with Polyneuropathy of Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with a V122I or T60A Mutation

  Ajroud-Driss, S. (PD/PI)

  Quintiles, Inc., Alnylam Pharmaceuticals, Inc.

  6/29/20 → 6/29/23

  Project: Research project

• Prot#US-SPN-17-11267: A Prospective, Multi-center, Open-Label, Observational Study of the Safety, Tolerability and Effectiveness of SPINRAZA in Adults with SMA

  Ajroud-Driss, S. (PD/PI)

  Washington University in St. Louis, Biogen Inc.

  5/14/20 → 5/14/23

  Project: Research project

• HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) C to Master Protocol CNM-Au8 | Double-Blind Phase

  Ajroud-Driss, S. (PD/PI) & Ajroud-Driss, S. (PD/PI)

  Massachusetts General Hospital

  3/23/20 → 12/31/23

  Project: Research project

• HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) B to Master Protocol Verdiperstat | Double-Blind Phase

  Ajroud-Driss, S. (PD/PI)

  Massachusetts General Hospital

  2/26/20 → 12/31/23

  Project: Research project